Clinical Trial Update: Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This document reports the completion of a randomized Phase II trial of SOL in untreated metastatic colorectal cancer, sponsored by Taiho Pharmaceutical Co., Ltd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SOL

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED